Primary and Secondary Endpoints
The pre-specified outcomes that determine trial success (primary), provide supporting evidence (secondary), or generate hypotheses (exploratory).
Definition
The primary endpoint is the pre-specified outcome on which the trial is statistically powered and on which trial success or failure is judged. Secondary endpoints provide supporting evidence, additional efficacy claims, safety, or quality-of-life, and are typically tested under a pre-specified hierarchical or alpha-allocation procedure to control multiplicity. Exploratory endpoints generate hypotheses for future studies and do not support label or coverage claims. Endpoint choice and ordering is the single most consequential design decision in a pivotal trial.What this means in practice
MedTech sponsors increasingly use composite primary endpoints (MACE in cardiovascular, KCCQ in heart failure) and pre-specify hierarchical secondary testing to maximize labelable claims.- •Adding endpoints during trial conduct, almost always destroys their interpretability.
- •Failing to control multiplicity across secondary endpoints, leaving label claims unsupported.
Related terms
Grouped by themeEditor's picks
· Hand-selected related conceptsBiomarker or intermediate outcome used as a substitute for a clinical endpoint in regulatory decisions.
Definitive clinical study designed to establish safety and effectiveness for marketing authorization.
Single endpoint combining multiple component outcomes (e.g., MACE = death + MI + stroke).
A trial designed to demonstrate that a new intervention is not worse than an active comparator by more than a pre-specified, clinically acceptable margin.
Clinical Trials & Evidence
· From this learning pathDeparture from the approved clinical investigation plan.
Trial design that pre-specifies opportunities to modify aspects (sample size, arms, endpoints) based on interim data.
Any untoward medical occurrence in a subject, whether or not related to the device.
Documented assessment of clinical data demonstrating EU MDR conformity for a device.
Primary references
3 sources- 1
FDA, Multiple Endpoints in Clinical Trials (2022)VerifiedFDAfda.gov
- 2
ICH E9(R1) EstimandsVerifiedICHich.org
- 3
ICH GuidelinesVerifiedICHich.org
Inline markers like [1] jump to the matching reference above.